CLINICAL TRIALS PROFILE FOR TESTOSTERONE UNDECANOATE
✉ Email this page to a colleague
All Clinical Trials for testosterone undecanoate
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00117000 ↗ | The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly | Unknown status | Organon | Phase 3 | 2003-07-01 | The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women. |
| NCT00117000 ↗ | The Effects of Testosterone and Nutritional Supplementation in the Undernourished Elderly | Unknown status | University of Adelaide | Phase 3 | 2003-07-01 | The purpose of this study is to determine what effect treatment for one year with testosterone and a nutritional supplement, alone and combined, has on the adverse effects of under-nutrition in community-dwelling older men and women. |
| NCT00119483 ↗ | Older Men and Testosterone | Completed | University Hospital of North Norway | N/A | 2005-09-01 | Male hypogonadism is a clinical situation characterized by a low serum testosterone level in combination with a diversity of symptoms and signs such as reduced libido and vitality, decreased muscle mass, increased fat mass and depression. Similar symptoms in combination with subnormal testosterone levels are seen in some elderly men. Low testosterone levels are associated with known cardiovascular risk factors, and men with diabetes and stroke have lower testosterone levels than healthy men. Even though several publications have suggested that testosterone treatment in hypogonadal men may have beneficial effects, it is still uncertain if testosterone substitution in the aging man is indicated. Despite this uncertainty the sale of testosterone has increased enormously the last few years. We hypothesize that older men with subnormal testosterone levels have a varying degree of dysfunction/symptoms both physically and mentally, and that these dysfunction/symptoms can be improved with testosterone treatment. |
| NCT00146146 ↗ | Testosterone and Its Metabolites in GID | Completed | Schering-Plough | Phase 3 | 2005-05-01 | The purposes of this study are: - to determine the role of testosterone versus dihydrotestosterone with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile - to determine the role of testosterone and dihydrotestosterone versus estradiol with respect to the following physiological functions: bone metabolism, body composition, insulin resistance and lipid profile |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for testosterone undecanoate
Condition Name
Clinical Trial Locations for testosterone undecanoate
Trials by Country
Clinical Trial Progress for testosterone undecanoate
Clinical Trial Phase
Clinical Trial Sponsors for testosterone undecanoate
Sponsor Name
